SIETES :: 92854 citas

Resultados de la búsqueda por ANALGÉSICOS REFINAR BÚSQUEDA

1.

2.

Ji Y, Azuine RE, Zhang Y, Hou W, Hong X, Wang G, Riley A, Pearson C, Zuckerman B, Wang X. Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry 2019:30 de octubre. [Ref.ID 103208]

3.

Smith BH, Fletcher EH, Calvin LA. Opioid prescribing is rising in many countries. BMJ 2019;367:17 de octubre. [Ref.ID 103203]

4.

Taylor P. J&J hit by $8bn judgment for man claiming breast growth due to Risperdal. PMLiVE 2019:9 de octubre. [Ref.ID 103192]

5.

Pfrepper C, Deters S, Metze M, Siegemund R, Gockel I, Petros S. Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients. Eur J Clin Pharmacol 2019;75:777-84. [Ref.ID 103175]

6.

Vélez AM. La dueña del monopolio del opio en España oculta los sueldos de su cúpula tras la salida del multimillonario Abelló . eldiario.es 2019:11 de septiembre. [Ref.ID 103173]

7.

Beddoes ZM. Johnson & Johnson, Purdue and other opioid-peddlers face a reckoning. The Economist 2019:1. [Ref.ID 103165]

8.

Finnerub NB. Nonnarcotic methods of pain management. N Engl J Med 2019;380:20 de junio. [Ref.ID 103139]

9.

Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]

10.

Samper E. La absurda historia del ibuprofeno de 600mg y el paracetamol de 1gr. eldiario.es 2019:31 de mayo. [Ref.ID 103127]

11.

Jeong S, Tchoe HJ, Shin JY. All-cause mortality associated with tramadol use: a case-crossover study. Drug Saf 2019;42:junio. [Ref.ID 103119]

12.

Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]

13.

Hedenmalm K, Slattery J, Skibicka-Stepien I, Kurz X, Morales D. Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016. Eur J Clin Pharmacol 2019;75:5. [Ref.ID 103092]

14.

Podolsky SH, Herzberg D, Greene JA. Preying on prescribers (and their patients) — Pharmaceutical marketing, iatrogenic epidemics, and the Sackler legacy. N Engl J Med 2019:10 de abril. [Ref.ID 103090]

15.

McGreal C. Primera condena penal al director de una farmacéutica por su papel en la epidemia de opiáceos que asola EEUU. eldiario.es 2019:3 de mayo. [Ref.ID 103089]

16.

Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf 2019;42:abril. [Ref.ID 103083]

17.

Torjesen I. Pregabalin and gabapentin: what impact will reclassification have on doctors and patients?. BMJ 2019;364:11 de marzo. [Ref.ID 103081]

18.

Samper E. El doble filo del ibuprofeno y otros antiinflamatorios . eldiario.es 2019:22 de abril. [Ref.ID 103079]

19.

Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med 2019;179:mayo. [Ref.ID 103073]

20.